Clinical Trials List
2021-09-22 - 2033-12-31
Phase III
Recruiting14
ICD-10C41.0
Malignant neoplasm of bones of skull and face
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9170.0
Malignant neoplasm of bones of skull and face, except mandible
-
Trial Applicant
QPS
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- Yi-Fang Tsai 無
- Ta-Chung Chao 無
- Chi-Cheng Huang 無
- Jiun-I Lai 無
- 陳彥蓁 無
- 邱仁輝 無
- 馮晉榮 無
- 賴亦貞 無
- 林燕淑 無
- Chun-Yu Liu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 蔡立威 無
- 林季宏 無
- MING-YANG WANG 無
- 張端瑩 無
- 林柏翰 無
- 郭文宏 無
- Wei-Wu Chen 無
- 陳怡君 無
- 羅喬 無
- YEN-SHEN LU 無
- 陳怡君 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 周旭桓 無
- Chan-Keng Yang 無
- Wen-Ling Kuo 無
- Wen-Chi Shen 無
- Chi-Chang Yu 無
- Mengting Peng 無
- 張潤忠 無
- 沈士哲 無
- Yung-Chang Lin 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jui-Hung Tsai 無
- Kuo-Ting Lee 無
- Zhu-Jun Loh 無
- 楊舜如 無
- Shang-Hung Chen 無
- Chun-Hui Lee 無
- Yao-Lung Kuo 未分科
- Wei-Pang Chung 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Jung Chen 無
- Chen-Teng Wu 無
- HWEI-CHUNG WANG 無
- 黃至豪 無
- Yao-Chung Wu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳維信 無
- 王國鐘 無
- I-Chen Tsai 無
- 林慈恩 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wei-Hong Cheng 無
- HUI-WEN LIU 無
- 莊博雅 無
- Yao-Yu Hsieh 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 甘蓉瑜 無
- Shen Liang Shih 無
- Fang-Ming Chen 無
- Chung-Liang Li 無
- 高理鈞 無
- Chieh-Han Chuang 無
- 巫承哲 無
- 高捷妮 無
- Junping Shiau Shiau 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
196 participants
-
Global
4100 participants
